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• SIRPIDs are a newly described group of EEG pattern, which is still not well characterized, 
and this study help clinicians to integrate this neurophysiologic information in clinical 
practice. 
• This study suggest that considerable brain insult is necessary to induce SIRPIDs 
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Objectives: To analyze the prevalence of Stimulus-induced rhythmic, periodic or ictal discharges 
(SIRPIDs) in patients with coma after cardiac arrest (CA) and therapeutic hypothermia (TH) and to 
examine their potential association with outcome.  
  
Methods: We studied our prospective cohort of adult survivors of CA treated with TH, assessing 
SIRPIDs’ occurrence and their association with 3-month outcome. Only univariated analyses were 
performed. 
 
Results: 105 patients with coma after CA who underwent electroencephalogram (EEG) during TH 
and normothermia (NT) were studied. Fifty-nine patients (56%) survived, and 48 (46%) had good 
neurological recovery. The prevalence of SIRPIDs was 13.3% (14/105 patients), of whom 6 
occurred during TH (all died), and 8 in NT (3 survived, 1 with good neurological outcome); none 
had SIRPIDS at both time-points. SIRPIDs were associated with discontinuous or non-reactive 
EEG background and were a robustly related to poor neurological outcome (p<0.001). 
 
Conclusion: This small series provides preliminary univariate evidence that in patients with coma 
after CA, SIRPIDs are associated with poor outcome, particularly when occurring during in 
therapeutic hypothermia. However, survival with good neurological recovery may be observed 
when SIRPIDs arise in the post-rewarming normothermic phase.  
 
Significance: This study provides clinicians with new information regarding the SIRPIDs prognostic 
role in patients with coma after cardiac arrest. 
  




While “stimulus-sensitive” neurological manifestations have been known for a long time in 
survivors of cardiac arrest (CA) (Niedermeyer et al., 1977),  a spectrum of stimulation-induced 
electroencephalographic patterns, called stimulus-induced rhythmic, periodic or ictal discharges 
(SIRPIDs) has recently been described (Hirsch et al., 2004); in the original report, these were 
found in 22% critically ill patients (including one subject with post anoxic coma out of 33 with 
SIRPIDs). As stated by the authors, neither the prognostic role nor the clinical implications of 
SIRPIDs were known, and this has not changed in the following years. To explore these aspects, 
the role of SIRPIDs was analyzed in comatose patients surviving a CA and treated with therapeutic 
hypothermia (TH).    
 
Methods 
Patients and procedures:  
We prospectively studied a cohort of consecutive adults treated in our 32-bed multidisciplinary 
intensive care unit (ICU) between April 2009 and February 2012 (34 months). This observational 
registry has been described elsewhere (Rossetti et al., 2010a), and has full approval by our ethics 
commission. Briefly, all patients treated with TH were included; TH was started immediately in the 
emergency room and continued in the ICU. Patients were cooled to 33 ± 1°C for 24 hours using ice 
packs and cold infusions for hypothermia induction and an automated surface-cooling device 
(Arctic Sun Temperature Management System, Medivance, Louisville, CO) for maintenance of 
stable mild hypothermia. All patients were given a standardized sedation-analgesia with 
midazolam (0.1 mg/kg/hr) and fentanyl (1.5 µg/kg/hr). Vecuronium was used to prevent shivering. 
Patients diagnosed as brain dead after rewarming were excluded. Withdrawal of care was decided 
after interdisciplinary discussion, based on clinical and electrophysiological findings, as recently 








A neurologist examined all patients after rewarming, off sedation. Neurological examination 
included testing of principal brainstem reflexes (pupillary, oculocephalic, corneal) and motor 
reactivity to painful stimulation. As often as possible, an electroencephalogram (EEG) was also 
obtained during TH (limited EEG technologist availability during overnight), and all patients had at 
least one EEG after rewarming and off sedation, in normothermia. Both recordings were realized 
with auditory and noxious stimulations performed by a physician at bedside. Most EEGs were 
recorded for 20 to 60 minutes (some for a longer time) on a portable digital machine (Viasys 
Neurocare, Madison, WI), using 21 (occasionally, 9 or 14) electrodes arranged in accordance to 
the international 10-20 system. EEGs were interpreted by certified electroencephalographers at 
bedside and post hoc, using bipolar and referential montages, with a filters setting of 0.5 and 70Hz, 
and a notch filter (50Hz). Bilateral median nerve somatosensory evoked potentials (SSEP) 
recordings were also performed by a certified technologist using a cephalic (Fpz) and 
extracephalic (contralateral ear) reference and interpreted by a certified neurologist. Serum 
neuron-specific enolase (NSE) was sampled at 24 and 48 with an automated imunofluorescent 
assay. 
Variables:  
Demographics, CA etiology, duration of CA (defined as the time from collapse to the return of a 
spontaneous circulation (ROSC)) were prospectively collected. Brainstem reflexes were 
categorized as all present or not. The motor response to pain was categorized as no response or 
extension posturing, vs. flexor response or better. Antiepileptic drugs (AED) administration was 
also recorded.  
EEG findings were categorized by experienced certified electroencephalographers according to 
three variables, as previously described (Rossetti et al., 2010b): 1) EEG background reactivity, 
defined as a clear and reproducible change in background frequency or amplitude following 
auditory or noxious stimulation, excluding SIRPIDs (see below) and muscle artifacts; 2) 
spontaneous discontinuous (burst-suppression) pattern, defined as an EEG background 
interrupted by very low-voltage (<5 µV) periods; 3) epileptiform activity, defined as any periodic or 
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rhythmic spikes, sharp waves, spike-waves, or rhythmic waves evolving in amplitude, frequency, or 
field. SIRPIDs were defined by the occurrence of rhythmic, periodic or ictal discharges after a 
stimulus, according to the original description (Hirsch et al., 2004);  the time relation between the 
SIRPIDs and the stimuli needed to be clearly within few seconds and reproducible. All EEG 
recordings with SIRPIDs that were also scored as “epileptiform” were reviewed to confirm this 
aspect independently of SIRPIDs.  
The N20 response on the SSEP was categorized as present or not. A negative deflection between 
18 and 25 ms after the simulation followed by a clear positive deflection was needed for the N20 to 
be considered as present. If the exam was not evaluable it was performed again. In case of 
doubtful interpretation, N20 was considered present. 
Outcome was assessed with mortality rate (during hospital stay) and with the Glasgow-Pittsburgh 
Cerebral Performance Categories (CPC) at three months, where good outcome is defined as CPC 
1 (no impairment) or 2 (moderate impairment) (Booth et al., 2004).  
Statistical analysis: 
Analyses were performed using two-tailed Fisher’s exact, χ2, or t tests, as required. Significance 
was assumed at p<0.05. Given the relatively low number of events (14 patients had SIRPIDs), no 
multivariable analysis was performed. 
 
Results 
During the studied period, 144 patients were treated with TH; 105 had an EEG during both TH and 
normothermia, the latter were recorded within 72 hours following CA. Table 1 illustrates 
demographics, etiology of CA and outcome of the studied cohort. Most patients were men and 
suffered from ventricular fibrillation. In hospital mortality was 46/105 (43.8%), while nearly half of 
patients (48/105; 45.7%) reached a good neurological outcome (CPC of 1-2) at 3 months. The 
mean delay between CA and the hypothermic EEG was 16 ± 6.6 hours. 
The prevalence of SIRPIDs was 13.3% (14/105 patients). Eight of them had a periodic pattern, 
while the others were equally distributed between rhythmic or ictal patterns (see figure 1 for 
examples). No patient showed SIRPIDs during both hypo- and normothermia. Comparison 
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between patients with SIRPIDs and controls is shown in Table 2. Baseline demographics, 
including age, initial CA rhythm and the time to ROSC did not differ significantly between patients 
with vs. without SIRPIDs. In contrast, subjects with SIRPIDs during TH were more likely to have a 
discontinuous (p=0.005) EEG background, while those with SIRPIDs during NT had a higher 
proportion of EEG with epileptiform background (p<0.001). SIRPIDs at any time were associated 
with elevated NSE > 33 µg/l (62% vs. 29% in patients without SIRPIDs, p=0.02), but this 
relationship was not found when the cut off was set at 80 µg/l (15.4% VS 18.2%, p=0.43). 
Regarding AED administration, seven patients received levetiracetam, five valproic acid (all were 
also treated with levetiracetam) and three propofol, in various combinations.  
Overall, SIRPIDs were associated with poor prognosis at 3 months (Table 3). When considering 
the time of SIRPIDs occurrence (during TH vs. NT), we found that none of the six patents with 
SIRPIDs during TH survived. In contrast, 3 out of 8 patients with SIRPIDs after rewarming during 
NT survived (all 3 had a reactive EEG background and presence of N20 on SSEP and two had 
present brainstem reflexes within 72 hours from CA). Only one of them had a favorable outcome 
(CPC 2): all his brainstem reflexes were present, without any myoclonus, his EEG background was 
reactive independently from SIRPIDs, which had a rhythmic pattern of SIRPIDs, N20 was 
bilaterally present and his NSE level was 10 µg/l. 
 
Discussion 
The principal finding of this study is that SIRPIDs are not uncommon in comatose survivors of CA 
(observed in 14 patients, corresponding to 13.3% of our cohort) and, in this series this pattern 
appears to be associated with a poor prognosis, particularly when occurring during TH. Survival 
and favorable functional ouctcome, however, may be observed when SIRPIDs appear after 
rewarming and in normothermic conditions, as it was the case in one out of 14 patients with 
SIRPIDs of our prospective cohort.  
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The prevalence of SIRPIDs in our cohort (13.3%) is lower than previously reported in a more 
heterogeneous group of neurological critically ill patients (Hirsch et al., 2004); this may be related 
the our homogenous etiology of brain dysfunction. 
Before the SIRPIDs’ definition, a small series of four patients presenting “stimulus-sensitive 
seizures” after CA also mentioned a catastrophic outcome with a mortality of 100% (Van Cott et 
al., 1996). Those findings and our results are in line with the hypothesis that SIRPIDs are 
associated with a dysfunction of subcortico-cortical projections secondary to severe brain damage 
and hyper-excitability (Hirsch et al., 2004). The strong associations of SIRPIDs with highly 
abnormal EEG background and with elevated serum NSE, both strong markers of neuronal injury 
as previously reported by our group (Rossetti et al., 2012), corroborate this hypothesis. Of note, 
the fact that a NSE level > 33 µg/l was associated with SIRPIDs and not a level > 80 µg/L possibly 
reflects that the injury should be severe enough to produce SIRPIDs, but not too serious. If the 
injury is too severe, neurons may be unable to produce those EEG pattern. Indeed, half of the 
patients from the control group with a NSE > 80 µg/L had value > 130 µg/L (max. 291 µg/L). 
The transient nature of SIRPIDs, with no patient showing this pattern during both hypo- and 
normothermia, suggests a dynamic process during hypoxic-ischemic injury. The fact that necrosis 
is generally induced by a more severe brain aggression than apoptosis (Banasiak et al., 2000) 
could explain the worse prognosis associated with earlier appearance of SIRPIDs: stimulus-
induced patterns appearing early (during TH) might reflect severe irreversible damage with 
neuronal loss in thalamo-cortical loops due to necrosis, whereas SIRPIDs in normothermia could 
be due to a slower neuronal death due to apoptosis, and thus may reflect a less severe and 
potentially reversible process leading to brain damage. The timing of the “necrosis-apoptosis 
continuum” described in several in vitro and in vivo models may corroborate this hypothesis. 
Indeed the entire process involved in neuronal apoptotic cell death may take several days while 
necrosis occurs after several hours only (Martin et al., 1998). Finally, the worse prognosis of 
patients with SIRPIDs during HT seems congruent with the inhibitory potential of TH towards 
seizures (Corry et al., 2008); therefore, SIRPIDs appearing despite TH may reflect a more severe 
damage and thus a worse outcome in analogy with seizures (Rossetti et al., 2012). 
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The ictal nature of SIRPIDs is still a matter of debate (Kaplan and Duckworth, 2011; Rossetti and 
Dunant, 2007; Zeiler et al., 2011), possibly because it is a group of different patterns: some are 
clearly ictal, showing electric seizures induced by stimulation (figure 1C), but other - may be 
classified as “periodic patterns” (figure 1B), whose ictal nature is very debatable. However, we 
found a strong association of SIRPIDs with a discontinuous/non-reactive EEG background in the 
early phase during TH, while, interestingly, later occurrence of SIRPIDs during NT was closely 
related to an epileptiform EEG background. This interesting observation supports the notion that 
periodic elements represent an “unstable interictal–ictal continuum” (Pohlmann-Eden et al., 1996).  
Our group previously reported favorable outcome in some selected patients with post-anoxic 
myoclonic status epilepticus in the immediate post-rewarming normothermic phase who had 
preserved brainstem reflexes and cortical SSPE responses, and a reactive EEG background 
(Rossetti et al., 2009). Here, we observed that survival may be possible with acceptable functional 
recovery at 3 months in patients with SIRPIDs during NT: because in this subset of patients 
SIRPIDs were associated with “epileptiform” EEG pattern, it could be inferred that patients with 
SIRPIDs during normothermia and with the previously described clinical and electrophysiological 
profile may warrant intensive care and AED therapy for a limited time. Indeed, the only patient who 
survived with good functional outcome presented the profile described above, and was given 
levetiracetam therapy.  
Our findings are partially limited by the relatively low numbers of patients with SIRPIDs and the 
exploratory nature of this study. Indeed, we were not able to address whether SIRPIDs had an 
independent prognostic value. Secondly, most patients had two punctual EEG and not continuous 
EEG monitoring. So it is possible that some SIRPIDs may have been missed due to their transient 
nature shown by our data. Also because of the limited EEG evaluation, we were not able to precise 
the duration of the SIRPIDs susceptibility. However, this analysis relies on a prospective EEG 
assessment and, to the best of our knowledge, represents the first attempt to answer to the 
relevant question of SIRPIDs’ relationship on prognosis in ICU patients.  
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In conclusion, SIRPIDs seems to reflect a severe brain damage. If appearing during therapeutic 
hypothermia after CA, this EEG pattern seems related to mortality, whereas survival can be hoped 
for some selected patients presenting SIRPIDs after rewarming. Our analysis expands current 
knowledge on electrophysiological prognostication in patients after cardiac arrest, but larger 
confirmatory studies assessing SIRPIDs in this setting are needed. 
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Figure 1: examples of SIRPIDs in comatose patients after cardiac arrest on bipolar montage. 
Colored marks on the top represent the time of painful stimuli. A) Rhythmic pattern. B) Periodic 
pattern. C) Ictal pattern; this evolving periodic pattern lasted for one minute, then decreased in 
amplitude and frequency over 30 seconds, and the suppressed background reappeared. 
 
Table 1: Demographics of 105 patients treated with TH  
Age, mean (+/-SD) 61.1 (12.8) 
Male gender, n (%) 78 (74.3) 
Cardiological variables   
Cardiac arrest due to ventricular 
fibrillation, n (%) 70 (66.6) 
Time to ROSC, mean (SD) 23.8 (20.2) 
Outcome   
In-hospital mortality, n (%) 46 (43.8) 
CPC 1–2 at 3 months, n (%) 48 (45.7) 
ROSC: return of spontaneous circulation – CPC: Glasgow-Pittsburgh Cerebral Performance Categories 
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Table 2: SIRPIDs characteristics and comparison between patients with SIRPIDs and controls. 
  SIRPIDS Controls p 
n=105 14/105 (13.3)* 91/105 (86.7)*   
    SIRPIDs characteristics 
   Rhythmic, n (%) 3 (21.4)** 
  Periodic, n (%) 8 (57.2) 
  Ictal, n (%) 3 (21.4)     
    Male gender, n (%) 10 (71.4)** 68 (74.7)** 0.241 (Fisher) 
Age, mean (SD) 59.2 (12.2) 62.4 (12.9) 0.39 (t) 
Cardiological variables       
Ventricular fibrillation cardiac arrest, 
n (%) 10 (71.4) 60 (65.9) 0.685 (Fisher) 
Mean time to ROSC, in minutes 
(SD) 21.5 (9.48) 24.1 (21.3) 0.65 (t) 
EEG background in hypothermia       
Non-reactive, n (%) 8(57.1) 31 (34.1) 0.096 (χ2) 
Discontinue – non-epileptiform, n 
(%) 12(85.7) 41 (40.1) 0.005 (χ2) 
Epileptiform 
(Epileptiform transients, PEDs or 
electrical seizures), n (%) 3 (21.4) 12 (13.2) 0.226 (Fisher) 
EEG background in 
normothermia       
Non-reactive, n (%) 2 (14.3) 15 (16.5) 0.835 (Fisher) 
Discontinue – non-epileptiform, n 
(%) 2 (14.3) 15 (16.5) 0.835 (Fisher) 
Epileptiform 
(Epileptiform transients, PEDs or 
electrical seizures), n (%) 11 (78.6) 14 (15.4) <0.001 (Fisher) 
SSEP        
Tested, n (%) 12 (85.7) 86 (94.5)   
Bilateral absence of N20, n (%) 4/12 (33.4) 18/86 (20.1) 0.17 (Fisher) 
NSE       
Available, n (%) 13 (92.9) 77 (84.6)   
Mean µg/l (SD) 47.5 (34) 44 (54.6) 0.82 (t) 
>33 µg/l, n (%) 8/13 (61.5) 22/77 (28.6) 0.02 (χ2) 
>80 µg/l, n (%) 2/13 (15.4) 14/77 (18.2) 0.43 (Fisher) 
Clinical signs       
Absence of one or more brainstem 
reflexes, n (%) 8 (57.1) 31 (34.4) 0.103 (χ2) 
Absence of motor response, n (%) 10 (71.4) 37 (41.1) 0.14 (Fisher) 
Presence of early myoclonus, n (%) 5 (35.7) 14 (15.6) 0.059 (χ2) 
EEG: electroencephalogram – NSE: neuron-specific enolase – PEDs: periodic epileptiform discharges – ROSC: return of 
spontaneous circulation – SSEP: somatosensory evoked potentials – SIRPIDs: stimulus-induced rhythmic, periodic or 
ictal discharges. *Row percentages; ** Column percentages 
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Table 3: Frequency of SIRPIDs occurrence and relation with therapeutic hypothermia in patients 
with good versus poor functional outcome 
  
CPC 1-2 (good 
outcome) 
CPC 3-5 (poor 
functional outcome) p 
n=105 48/105 (45.7)* 57/105 (54.3)*   
SIRPIDs       
In hypothermia, n (%) 0 (0)** 6 (10.5)** 0.023 (Fisher) 
In normothermia, n (%) 1 (2.1) 7(12.3) 0.046 (Fisher) 
In hypothermia or 
normothermia, n (%) 1 (2.1) 13 (22.8) <0.001 (Fisher) 
CPC: Glasgow-Pittsburgh Cerebral Performance Categories 
* Row percentages; ** Column percentages 

